Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Media, Education & Engagement
Media & CommunicationGeneral Media Outlets
Media, Education & Engagement

NPR

Data updated

United States

U.S. public media network with recurring psychedelic reporting across science, health, policy, and patient-outcome narratives.

Media & Communication Snapshot

General Media Outlets

Cadence

Daily

Access

Free

Psychedelic Focus

Psychedelic-Adjacent Focus

Verification

Verified

Audience

General Public

Coverage Focus

Research & SciencePolicy & LegalCulture & Community

Media Notes

NPR is a US public media network publishing free daily news across radio, podcasts and the web. Its health and science desks regularly cover psychedelic research and policy, including the FDA's 2024 MDMA decision, psilocybin trials for smoking cessation and depression, and federal moves to fast-track psychedelic drug reviews. Psychedelics are one topic within its broad general-interest coverage rather than a dedicated focus.

Verification

Verified

Last Verified

Jul 11, 2026

Primary Media Link

Source Evidence

NPR

https://www.npr.org/

NPR: FDA rejects MDMA therapy application

https://www.npr.org/sections/shots-health-news/2024/08/09/nx-s1-5068634/mdma-therapy-fda-decision-ptsd-psychedelic-treatment

Quick Facts

Type
Non-Profit
HQ
United States
Website
Visit